Triflusal is a platelet aggregation inhibitor derived from acetylsalicylic acid, with a trifluoromethyl group replacing a hydrogen atom on the benzene ring. It is used as an active pharmaceutical ingredient in manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Triflusal?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Prasugrel
platelet aggregation inhibitor
Eptifibatide
pharmaceutical raw material
Calcitriol
pharmaceutical raw material
Melphalan hydrochloride
pharmaceutical raw material
Ornithine aspartate
pharmaceutical raw material
N6-Hydroxymethyl Adefovir Dipivoxil
pharmaceutical raw material
The international HS code for Triflusal (CAS 322-79-2) is 2918.29.
2918.29
2918 29 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-acetyloxy-4-(trifluoromethyl)benzoic acid
RMWVZGDJPAKBDE-UHFFFAOYSA-N
CC(=O)OC1=C(C=CC(=C1)C(F)(F)F)C(=O)O
Sourcing Triflusal?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.